BONUS!!! Download part of DumpsTests ALS-Con-201 dumps for free: https://drive.google.com/open?id=1cvEDnI90IqVR0ShtUyLha_6beKzgkZ1y
You may be busy in your jobs, learning or family lives and can't get around to preparing and takes the certificate exams but on the other side you urgently need some useful ALS-Con-201 certificates to improve your abilities in some areas. If you choose the test ALS-Con-201 certification and then buy our ALS-Con-201 prep material you will get the panacea to both get the useful ALS-Con-201 certificate and spend little time. Passing the ALS-Con-201 test certification can help you stand out in your colleagues and have a bright future in your career.
| Section | Objectives |
|---|---|
| Topic 1: Customer Engagement and Field Operations | - Territory and Account Management
|
| Topic 2: Agentforce and AI Capabilities | - AI and Automation
|
| Topic 3: Agentforce Life Sciences Consulting Fundamentals | - Industry and Regulatory Context
|
| Topic 4: Data, Compliance, and Governance | - Data Management
|
Free update for 365 days for ALS-Con-201 study guide materials is available. That is to say, in the following year, you can get the latest information of the exam for free. Besides, our system will send the latest version of ALS-Con-201 exam dumps to your email automatically. And you just need to receive them and carry on your practice. With the experienced experts to compile ALS-Con-201 Study Guide materials, the quality can be guaranteed. And if you choose us, we will help you pass the exam successfully, and obtaining a certificate isnโt a dream.
NEW QUESTION # 24
Choose 1 option.
A field sales rep attempts to add Immunexis to the Product Detailing section during a visit, but the product does not appear in the search results. The product record exists in Salesforce. The product must be explicitly enabled for use in visit discussions.
What should be configured in the Visit Administration tile on the Agentforce Life Sciences for Customer Engagement Admin Console?
Answer: C
Explanation:
The correct answer is B because the product must be enabled for discussion in the visit-detailing experience. Salesforce's Life Sciences Visit Management developer documentation states that information entered in a provider visit typically includes product details, product messages, presentations, marketing items, and samples. Salesforce Trailhead also explains that Life Sciences Cloud uses product administration and product-message configuration to ensure reps only promote and discuss therapies within approved guardrails.
The scenario says the product exists in Salesforce, but it does not appear when the rep tries to add it to the Product Detailing section during a visit. That means the issue is not product creation; it is visit-discussion eligibility. The consultant should configure Product Discussion Settings in the Visit Administration area so Immunexis is available for product detailing and visit discussions.
Option A is incorrect because Territory Product Alignment Rules determine which products are aligned to territories, but the question specifically says the product must be explicitly enabled for use in visit discussions. Territory alignment alone does not guarantee the product appears in the Product Detailing search. Option C is also incorrect because Visit Record Type Mappings control record-type behavior, not whether a product can be discussed. Therefore, the correct configuration is Product Discussion Settings.
NEW QUESTION # 25
Choose 1 option.
Cumulus Pharma uses Agentforce Life Sciences for Customer Engagement to provide Account Summaries. The Agentforce Life Sciences Consultant configured a Cross-Object Field History Graph to include related Provider Visit and Medical Inquiry records. Key Account Managers report that summaries include all related data; however, field sales reps report that their summaries exclude visit and inquiry data. Both user groups have Read access to the underlying objects.
What is the cause of this issue?
Answer: B
Explanation:
The correct answer is A because Account Summarization can use different Cross-Object Field History Graph assignments by org or profile. Salesforce Help for Life Sciences Account Summarization states that administrators can create a Cross-Object Graph for Account Summarization and assign cross-object graphs to an org or profile. Salesforce also describes the Account Summarization workflow as using configured cross-object field history so summaries can include recent and relevant account changes from related objects.
In this case, KAMs see summaries that include Provider Visit and Medical Inquiry records, while field sales reps do not. Both groups have Read access to the objects, so object permission is not the root cause. The difference is most likely profile-based summarization configuration: the graph containing Provider Visit and Medical Inquiry data has been assigned to the KAM profile but not to the field sales rep profile.
Option B is incorrect because Account Summary generation in this scenario is driven by Cross-Object Field History Graph configuration, not membership in a Data 360 segment. Option C is also incorrect because the question explicitly says both user groups have Read access. View All is not the stated requirement for using a graph in summarization. Therefore, the issue is that the Cross-Object Field History Graph is not assigned to the field sales rep profile.
=========
NEW QUESTION # 26
Choose 1 option.
Cumulus Pharma requires the Agentforce Life Sciences for Customer Engagement Account Summary to include historical data from the Account record and related Healthcare Provider and Contact Point Address records.
Which configuration defines the object relationships for this summary?
Answer: C
Explanation:
Option A is correct because Account Summarization uses a cross-object graph to define which objects and relationships are included in the generated summary. Salesforce Help states that administrators can create cross-object graphs from a predefined Account Summarization template to provide a complete view of an account and its related objects. This directly matches the requirement to include Account data and related Healthcare Provider and Contact Point Address information in the summary.
The phrase "historical data" is also important. Salesforce Account Summarization setup includes configuring history tracking for the fields included in the template, so Agentforce can summarize recent changes from the selected objects and fields. The cross-object graph defines the relationship structure, while field history tracking provides the change history used in the summary.
Option B, Actionable Relationship Center, is not the best answer. Actionable Relationship Center is used to visualize related records and relationships, but the Account Summary configuration specifically relies on cross-object graphs. Option C, Affiliation Alignment Rules, is unrelated because those rules support territory alignment for affiliated accounts, not Account Summary object relationships. Therefore, the consultant should use a Cross-Object Field History Graph to define the Account, Healthcare Provider, Contact Point Address, and related-object structure used by Agentforce Account Summary.
=========
NEW QUESTION # 27
Choose 1 option.
An Agentforce Life Sciences Consultant uses the Account Summarization template to create a cross-object graph for a Life Sciences organization. Users report that the Agentforce summaries successfully include related data but fail to show recent updates made to specific Healthcare Provider Account fields.
What should the consultant configure to ensure the summary reflects the latest changes to these records?
Answer: B
Explanation:
Option A is correct because Salesforce Life Sciences Account Summarization uses field history tracking to include the latest changes for configured fields. Salesforce Help states that, to get summaries of the latest changes in a record, history tracking must be enabled for the fields configured in the Account Summarization template. This directly matches the issue: the summaries include related data, but recent updates to specific HCP Account fields are missing. The consultant must enable history tracking for the relevant fields so Agentforce can use those tracked changes when generating the account summary.
Feed tracking is not the best answer because Chatter feed tracking is primarily used to publish field changes to the record feed for collaboration and visibility. It does not satisfy the specific Account Summarization requirement documented by Salesforce. Field Audit Trail is also not correct for this scenario. Field Audit Trail is a Salesforce Shield capability used for long-term retention and audit-policy management of field history data, but the Account Summarization setup requirement is specifically field history tracking for the fields included in the template. Salesforce's Account Summarization Data Setup documentation also confirms that the Provider Summary Lightning App Builder component can be configured to enable history tracking for fields included in the information summary.
Therefore, the consultant should enable history tracking for the Account fields configured in the Account Summarization template.
=========
NEW QUESTION # 28
Choose 1 option.
Cumulus Pharma is preparing for the commercial launch of a new product, "Immunexis." The sales operations director wants to implement a strategic sampling control that is not required by law, but is critical for inventory management. The requirements for this rule are:
Period Logic: The limit period must dynamically begin on the Product Launch Date rather than the standard Calendar Year.
Enforcement: To avoid blocking sales momentum, the system must only display a warning, or soft limit, if a rep exceeds the allocated quantity, allowing the rep to proceed with the disbursement if necessary.
Which Sample Limit Template type meets these requirements?
Answer: C
Explanation:
Option C is correct because Advanced Sample Limit Templates are designed for custom, complex sample-limit rules. Salesforce Help explains that advanced sample limit templates are used to define custom sample limit rules for more complex needs and stricter requirements. This scenario requires two non-basic behaviors: a dynamic period start based on the product launch date and soft-limit enforcement that warns the rep but still allows the disbursement to proceed. Those requirements go beyond a generic calendar-year rule.
A Generic Sample Limit Template is not the best answer because generic templates are better suited for standard sample-limit logic. The requirement explicitly says the limit period must begin on the Product Launch Date rather than the standard Calendar Year, which makes the rule more specialized. A Country Sample Limit Template is also not correct because country templates are used for country-specific legal or regulatory sampling limits. In this question, the control is strategic and inventory-driven, not a legal requirement tied to a specific country.
Advanced templates are the correct fit because they allow more flexible configuration for business-specific sample controls, including nonstandard periods and warning-based enforcement. Therefore, the consultant should use an Advanced Sample Limit Template for the Immunexis launch sampling rule.
=========
NEW QUESTION # 29
......
These Salesforce Certified Agentforce Life Sciences Consultant (ALS-Con-201) practice test questions are customizable and give real Salesforce Certified Agentforce Life Sciences Consultant (ALS-Con-201) exam experience. Windows computers support desktop software. The web-based ALS-Con-201 Practice Exam is supported by all browsers and operating systems.
ALS-Con-201 Free Pdf Guide: https://www.dumpstests.com/ALS-Con-201-latest-test-dumps.html
2026 Latest DumpsTests ALS-Con-201 PDF Dumps and ALS-Con-201 Exam Engine Free Share: https://drive.google.com/open?id=1cvEDnI90IqVR0ShtUyLha_6beKzgkZ1y